Health & Biotech

Percheron could double if clinical goes well. Probiotec meanwhile offers a a resilient business model, says Sequoia.

Investor interest in the North American cannabis sector is surging as the US Congress moves closer to passing key legislation…

AdAlta and SYNthesis BioVentures Fund (SYNBV) are collaborating to form AdCella, a jointly owned entity aimed at facilitating the entry…

Blinklab (ASX:BB1) has became the first healthcare IPO so far of 2024 listing on April 4 with an impressive 32.5%…

Health and wellness company The Calmer Co has reported a 25% increase in monthly online sales compared to February, with…

Imricor is at the forefront in advancing MRI-compatible products for US$8 billion cardiac catheter ablation market.

There are signs the healthcare space is coming back to life after a hard 2023. Six ASX healthcare companies fronted…

Acrux announced launch of acne gel in the US. Recce Pharma granted Israeli patent for its anti-infectives R327 and R529.

Anteris Technologies (ASX:AVR) has developed the world’s first, single piece transcatheter aortic valve called the DurAVR THV.

Optiscan is beefing up its presence in the US as it works toward securing US regulatory approvals for its confocal…